Skip to main content
Mercator Medical logo

Mercator Medical — Investor Relations & Filings

Ticker · MRC ISIN · PLMRCTR00015 LEI · 259400YONW18M3H4WX66 WAR Manufacturing
Open in API
Filings indexed 1,123 across all filing types
Latest filing 2022-09-29 Earnings Release
Country PL Poland
Listing WAR MRC

About Mercator Medical

https://en.mercatormedical.eu/

Mercator Medical is a manufacturer of medical gloves and a distributor of single-use medical materials. The company's core product portfolio includes a variety of disposable gloves, such as surgical, diagnostic, sterile, and protective types, alongside other disposable medical supplies. It operates on a dual model: as a manufacturer with a global distribution network selling to numerous countries worldwide, and as a distributor primarily focused on European markets. The business centers on providing single-use medical devices and personal protective equipment.

Recent filings

Filing Released Lang Actions
Aktualizacja szacunkowych wyników drugiego kwartału 2022 r. - Content (PL)
Earnings Release Classification · 100% confidence The document is a current report (raport bieżący) from Mercator Medical S.A. It revises previously released preliminary financial estimates for the second quarter of 2022 (Q2 2022), specifically detailing changes to consolidated EBITDA, net loss, and sales revenue. It also mentions changes in net cash position. Crucially, the final sentence states: "Skonsolidowany raport półroczny Grupy Emitenta za pierwsze półrocze 2022 r. zostanie przekazany w dniu 30 września 2022 r." (The consolidated semi-annual report of the Issuer Group for the first half of 2022 will be delivered on September 30, 2022). Since this document is an announcement revising preliminary results and *announcing* the future release date of the full semi-annual report, it is not the full Interim Report (IR) itself. It is an announcement related to financial results, but its primary function here is updating figures rather than being the initial, comprehensive release (ER) or the final, comprehensive report (IR). Given the content focuses on specific financial metrics adjustments and is short (1266 chars), it fits best as an Earnings Release (ER) which often includes preliminary or revised figures, or potentially a Regulatory Filing (RNS) if it doesn't fit ER well. However, because it explicitly deals with the revision of key quarterly financial metrics (EBITDA, Net Loss, Revenue), it aligns most closely with the spirit of an Earnings Release (ER), even if it's a revision/update rather than the initial release. If the document were purely announcing the release date of the IR, RPA would be better, but here the core content is the revised numbers. I will classify it as ER due to the focus on revised quarterly financial highlights. Q2 2022
2022-09-29 Polish
Powzięcie informacji o zabezpieczeniu roszczenia o stwierdzenie nieważności uchwał Nadzwyczajnego Walnego Zgromadzenia Mercator Medical S.A. z dnia 27 lipca 2022 r - Content (PL)
Legal Proceedings Report Classification · 99% confidence The document is a formal announcement from the Management Board ('Zarząd spółki') of Mercator Medical S.A. regarding a court ruling ('postanowienia o udzieleniu... zabezpieczenia roszczenia') that restricts the company from reselling its own shares ('zakazanie Spółce dalszego odsprzedawania 876.731 akcji własnych'). This directly concerns the company's treasury stock transactions and capital structure management, specifically involving shares the company previously acquired. This type of legal/regulatory action impacting share ownership and capital management fits best under 'Transaction in Own Shares' (POS) or potentially 'Legal Proceedings Report' (LTR). Since the core subject is the restriction on the use/sale of treasury shares, POS is the most specific fit, as it deals with the company's own shares. It is not a general earnings release, annual report, or management change announcement. Given the specific nature of the court order restricting the disposal of treasury shares, POS is selected over LTR.
2022-09-16 Polish
Zmiana terminu przekazania skonsolidowanego raportu półrocznego - Content (PL)
Report Publication Announcement Classification · 100% confidence The document text is very short (407 characters) and explicitly states that the company (Mercator Medical S.A.) is informing about a CHANGE IN THE DATE ('zmianie terminu') for releasing its consolidated semi-annual report ('skonsolidowanego raportu półrocznego') for the first half of 2022. It announces the new release date (September 30, 2022) versus the previously scheduled date (September 15, 2022). This is not the report itself (which would be an IR), but an announcement about the timing/publication schedule of a report. According to Rule 2 (The 'Menu vs Meal' Rule), a short announcement regarding the publication or timing of a report points towards RPA or RNS. Since this is a specific announcement about the timing of an Interim Report (IR), Report Publication Announcement (RPA) is the most fitting category.
2022-09-09 Polish
Rezygnacja osoby zarządzającej - Content (PL)
Board/Management Information Classification · 98% confidence The document text, written in Polish, announces the resignation of a Management Board Member (Członek Zarządu Spółki), Pan Michał Romański, effective immediately on August 25, 2022, citing personal reasons. This directly corresponds to the definition of Board/Management Information, which covers announcements of changes in senior management.
2022-08-26 Polish
Informacje udzielone Akcjonariuszowi
AGM Information Classification · 99% confidence The document is a formal response dated August 10, 2022, to an information request made by a shareholder during an Extraordinary General Meeting (Nadzwyczajne Walne Zgromadzenie) on July 27, 2022. The request specifically concerns the status, location, and trading history of the company's own shares held for cancellation (akcji własnych przeznaczonych do umorzenia). Key indicators: 1. It addresses a shareholder request made during a General Meeting. 2. It provides detailed information about the company's treasury stock (own shares). 3. The content is a direct answer to specific shareholder inquiries, rather than a standard periodic financial report (like 10-K or IR) or a general announcement. 4. The context strongly relates to shareholder rights, meeting outcomes, and corporate governance regarding capital structure. This type of detailed response to shareholder inquiries following a meeting, especially concerning capital structure (own shares), is often classified under governance or specific shareholder communication. However, given the options, the document is a formal communication providing specific details requested by shareholders, which aligns best with the scope of shareholder/governance communication, but it is not a standard AGM presentation (AGM-R) or a declaration of voting results (DVA). Since the document is a detailed, formal response to shareholder inquiries regarding the status of own shares (a matter of corporate structure and governance), and it is not a standard regulatory filing form (like 10-K, IR, ER), it fits best as a specific type of corporate governance or shareholder communication. Given the available codes, it is a specific response related to shareholder rights and corporate actions. It is not a proxy statement (PSI) or a remuneration report (DEF 14A). It is a direct response to an inquiry made at an EGM. If the inquiry was about voting results, DVA would apply, but it's about share status. Since it's a detailed response to shareholder queries, it falls under general corporate reporting, but the closest fit among the specific options related to shareholder meetings and corporate structure is difficult. However, it is a formal letter providing specific data requested by shareholders, which often gets categorized as a Regulatory Filing (RNS) if no better fit exists, or potentially related to Governance (CGR) or Share Issue (SHA) due to the topic. Given the context of responding to a shareholder request made at an EGM, and the detailed nature of the response, it is a specific corporate disclosure. It is not an announcement of a report (RPA). It is a direct disclosure. I will classify it as RNS as a formal, specific disclosure that doesn't fit the other precise categories like ER, 10-K, or DIV, but is clearly a formal communication. Revisiting the definitions: It is a formal letter providing information requested by a shareholder following an EGM. This is a specific type of corporate disclosure. It is not a standard financial report. It is not a Director's Dealing (DIRS). It is not a Dividend Notice (DIV). It is not a Capital Update (CAP) in the sense of raising new capital, but about treasury stock. Given the lack of a perfect fit for 'Shareholder Inquiry Response', RNS (Regulatory Filings - general fallback) is the most appropriate category for this specific, non-standard disclosure.
2022-08-11 Polish
Informacje udzielone akcjonariuszowi poza walnym zgromadzeniem, na podstawie art. 428 § 5 Kodeksu spółek handlowych - Content (PL)
Legal Proceedings Report Classification · 99% confidence The document text is very short (311 characters) and is written in Polish. The key phrases are "przekazuje w załączniku do niniejszego raportu bieżącego informacje" (transmits in the attachment to this current report information) and mentions information provided in response to a request made during an Extraordinary General Meeting ("Nadzwyczajnego Walnego Zgromadzenia"). This structure strongly suggests an announcement about information being provided, rather than the full information or report itself. Since it is an announcement related to a regulatory filing context (a 'raport bieżący' or current report) concerning shareholder meeting follow-up, and it doesn't fit perfectly into AGM-R (which is usually the presentation) or DVA (which is the voting result), the most appropriate general category for an announcement of information being provided via an attachment in a current report context, especially when the content is procedural or supplementary, is the general Regulatory Filings category (RNS), or potentially RPA if it were announcing a formal report publication. Given the context of responding to a request from an EGM, RNS serves as the best fit for a miscellaneous regulatory communication.
2022-08-11 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.